Anzeige
Mehr »
Login
Samstag, 22.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 21.02.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
FrMendus - CADENCE trial enrols first patient157Mendus has announced that the first patient has been enrolled in the CADENCE trial, sponsored by the Australasian Leukaemia and Lymphoma Group (ALLG). This is a multi-centre, randomised, controlled...
► Artikel lesen
FrMendus (OMX: IMMU) notes first patient enrolment in the CADENCE trial169Mendus has announced that the first patient has been enrolled in the Phase II AMLM22-CADENCE trial, sponsored by the Australasian Leukaemia and Lymphoma Group. The trial is a multicentre, randomised...
► Artikel lesen
FrPinewood (LSE: PINE) buys Seez199Pinewood has announced that it intends to acquire the remaining 90.9% stake in Seez for a total cost of $42m/£33.3m (Pinewood acquired an initial stake in Seez in September 2024 for $4.2m/£3.43m). Seez...
► Artikel lesen